Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,284.00
Bid: 2,287.00
Ask: 2,288.00
Change: 43.00 (1.92%)
Spread: 1.00 (0.044%)
Open: 2,247.00
High: 2,292.00
Low: 2,242.00
Prev. Close: 2,241.00
HLMA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

27 Sep 2017 07:00

RNS Number : 8921R
Halma PLC
27 September 2017
 

Halma plc

 

Trading Update

 

27 September 2017

 

Trading Update

 

Halma, the leading safety, health and environmental technology group today releases its scheduled Trading Update, relating to trading for the period from 2 April 2017.

 

Halma made good progress in line with the Board's expectations. The improved rates of organic constant currency revenue and profit growth achieved in the second half of the last financial year have continued into the current year. Order intake was ahead of revenue and also ahead of the same period last year.

 

There was widespread growth geographically, with organic constant currency revenue increases in all major regions. Asia Pacific maintained strong growth, with good progress in the UK and Mainland Europe and a steady performance in the USA.

 

The Environmental & Analysis sector performed particularly well, benefitting from strong growth in Asia Pacific and the re-organisation in its Life Science and Research business during the first half of last year.

 

The improved performance achieved by the Process Safety sector in the second half of last year continued. Market diversification and rising demand from the US onshore energy market both contributed to significant growth over the prior year.

 

The Infrastructure Safety sector continued to achieve good growth as greater investment in new product development in recent years contributed towards increasing demand from Asia Pacific and Mainland Europe.

 

The Medical sector also achieved solid revenue growth, although profitability was lower due to increased investment in new product development and sales resources.

 

In August 2017, we announced the acquisitions of Cardios for an initial consideration of R$50m (£12.1m) and CASMED for $4.5m (£3.4m). Both businesses strengthen our Medical sector's blood pressure monitoring technology base, with Cardios also being Halma's first acquisition in Brazil. The integration of both businesses is progressing well.

 

Our M&A pipeline strengthened during the period. We continue to search for businesses in, or adjacent to, all four sectors and the additional sector resources added during 2016 have improved both the quantity and quality of our opportunities.

 

Cash generation was good and the Group's financial position remains strong.

 

The results for the half year ending 30 September 2017 will be released on 21 November 2017.

 

 

 

 

For further information, please contact:

 

Halma plc Tel: +44 (0)1494 721111

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

 

MHP Communications Tel: +44 (0)20 3128 8100

Rachel Hirst/Andrew Jaques

 

 

Notes:

 

1.

This Trading Update is based on unaudited management accounts information and has been prepared solely to provide additional information to the shareholders of Halma plc. It should not be relied on by any other party, for other purposes. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

2.

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBLGDCUDDBGRL
Date   Source Headline
3rd Apr 201310:22 amRNSTotal Voting Rights
21st Mar 20137:00 amRNSTreasury Stock
20th Mar 20136:07 pmRNSHolding(s) in Company
15th Mar 20137:00 amRNSAcquisition
1st Mar 201311:33 amRNSTotal Voting Rights
21st Feb 201312:47 pmRNSDirector/PDMR Shareholding
14th Feb 20132:00 pmRNSHalma - New Reporting Sectors
14th Feb 20137:00 amRNSInterim Management Statement
1st Feb 20132:32 pmRNSTotal Voting Rights
24th Jan 20132:15 pmRNSTreasury Stock
23rd Jan 20139:00 amRNSAcquisition
18th Jan 201312:16 pmRNSBlocklisting Interim Review
2nd Jan 20133:51 pmRNSTotal Voting Rights
21st Dec 20123:36 pmRNSDirector/PDMR Shareholding
19th Dec 20127:00 amRNSAcquisition
14th Dec 20123:32 pmRNSTreasury Stock
3rd Dec 201210:48 amRNSTotal Voting Rights
26th Nov 201211:10 amRNSHolding(s) in Company
23rd Nov 20125:11 pmRNSTreasury Stock
23rd Nov 20122:21 pmRNSDirector/PDMR Shareholding
20th Nov 201212:25 pmRNSDoc re. Half Year Report 2012/13
20th Nov 20127:00 amRNSHalf Yearly Report
16th Nov 20124:27 pmRNSTreasury Stock
12th Nov 20122:52 pmRNSNotice of Results
1st Nov 20124:33 pmRNSTotal Voting Rights
30th Oct 20129:36 amRNSTreasury Stock
2nd Oct 20125:03 pmRNSDirector/PDMR Shareholding
1st Oct 20123:08 pmRNSTotal Voting Rights
27th Sep 20125:08 pmRNSTreasury Stock
21st Sep 20124:07 pmRNSTreasury Stock
21st Sep 20123:49 pmRNSHolding(s) in Company
20th Sep 20124:24 pmRNSTreasury Stock
6th Sep 20123:37 pmRNSTreasury Stock
3rd Sep 201211:35 amRNSTotal Voting Rights
31st Aug 20123:10 pmRNSDirector/PDMR Shareholding
23rd Aug 20127:00 amRNSDisposal
14th Aug 20129:00 amRNSAnnual Information Update
8th Aug 20129:34 amRNSShare Transactions and Purchase of Own Shares
2nd Aug 201212:17 pmRNSBlocklisting Interim Review
1st Aug 20123:14 pmRNSTotal Voting Rights
25th Jul 20122:57 pmRNSDirector/PDMR Shareholding
25th Jul 20122:51 pmRNSResult of AGM
24th Jul 20127:00 amRNSAGM Statement
3rd Jul 20129:39 amRNSTotal Voting Rights
25th Jun 201211:26 amRNSAnnual Financial Report
14th Jun 20127:00 amRNSFinal Results
8th Jun 20128:41 amRNSNotice of Results
1st Jun 201212:04 pmRNSTotal Voting Rights
31st May 20121:50 pmRNSDirector Declaration
31st May 20129:27 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.